Topline Results from First Phase 3 Trial of pSivida’s Medidur™ Presented at ASRS Annual Meeting
August 15, 2016 09:00 ET
|
pSivida Corp
WATERTOWN, Mass., Aug. 15, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases,...
Primary Endpoint Met in pSivida’s Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
August 09, 2016 10:00 ET
|
pSivida Corp
WATERTOWN, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV); (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases,...